PLX-4720

Products

ace

Inquiry

ace

* First Name
* Last Name
* Business Email
Phone
Company/Institution
Job Title
* Services or Products of Interest (DIA-0230397) PLX-4720
When do you expect your project to start?
Project Description
* All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
* Tick to confirm the Research Use Only (RUO) statement.

PLX-4720

Inquiry

Cat. No.: DIA-0230397

Size: 50 mg Size: 500 mg Size: Customer Size

Product Information
CAS No.	918505-84-7
Formula	C₁₇H₁₄ClF₂N₃O₃S
Molecular Weight	413.83
SMILES	CCC[S](=O)(=O)NC1=CC=C(F)C(=C1F)C(=O)C2=C[NH]C3=NC=C(Cl)C=C23
Target	c-Raf-1
Product Description	PLX4720 is a potent and selective inhibitor of B-RafV600E with IC50 of 13 nM in a cell-free assay, equally potent to c-Raf-1(Y340D and Y341D mutations), 10-fold selectivity for B-RafV600E than wild-type B-Raf.

Format & Storage
Purity	> 99%
Shipping	Shipped on dry ice.
Storage	Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month
Solubility Overview	Soluble in DMSO

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links

Contact Info

Copyright © Ace Therapeutics. All Rights Reserved.

Top